GET DAILY SIGNALSCBIZ (CBZ) Readies Q3 2026 Earnings: Tracking Post-Marcum Growth
Key Takeaways
- CBIZ, Inc. (NYSE: CBZ) is scheduled to report third-quarter 2026 results after the market closes on Wednesday, October 28, 2026.
- Consensus estimates call for adjusted earnings per share (EPS) of about $1.28 on revenue near $727 million.
- The EPS figure would represent roughly 26.7% growth from $1.01 in the year-ago quarter, while revenue is seen rising about 4.8%.
- CBIZ has beaten consensus EPS estimates in seven of its last eight quarters, a track record investors will be watching closely.
- Key themes include organic growth, Marcum integration synergies, and any updates to full-year 2026 guidance.
Why This Earnings Report Matters
As a leading professional services advisor to middle-market businesses, CBIZ generates revenue across accounting, tax, advisory, benefits, insurance, and technology services. The company is still absorbing its transformative acquisition of Marcum, which roughly doubled its scale and is now largely integrated. This quarter matters because it offers a read on whether CBIZ can convert that larger platform into sustained organic growth and margin expansion. It also tests management's assertion that demand pushed into 2026 would materialize, making the third-quarter print a key checkpoint for both revenue momentum and the company's full-year earnings trajectory.
What Analysts Are Expecting
For the quarter ended September 30, 2026, analysts expect adjusted EPS of approximately $1.28, up from $1.01 in the same period last year. Revenue is projected to reach roughly $727 million, a year-over-year increase of about 4.8% from $693.8 million.
These projections build on a strong recent track record. In the second quarter of 2026, CBIZ posted adjusted EPS of $0.91, beating consensus of $0.78, on revenue of about $682.2 million. The company has exceeded consensus EPS estimates in seven of its last eight quarters. For the full year, management has guided to revenue of roughly $2.8 billion to $2.9 billion and adjusted EPS of approximately $3.75 to $3.85, giving investors a benchmark against which to judge any third-quarter commentary or revisions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
How the Market Might React
Heading into the third-quarter report, sentiment around CBIZ has been shaped by its consistent earnings beats and the completion of the Marcum integration. The stock's reaction will likely hinge on whether the company can extend its beat streak and reaffirm or raise its full-year outlook. A key sensitivity is organic growth: because the Marcum acquisition distorts year-over-year comparisons, investors will focus on underlying, same-store revenue trends rather than headline growth. Any indication that client demand is softening, or that margin synergies are arriving slower than expected, could weigh on sentiment despite otherwise solid headline numbers.
Looking Ahead: Factors to Watch
Beyond the third-quarter headline figures, several factors will shape CBIZ's trajectory into 2027. First, watch organic revenue growth. With the Marcum deal now largely integrated, investors are increasingly judging the company on its ability to grow the combined business through cross-selling and new client wins rather than acquisition-driven expansion.
Second, monitor margin and synergy realization. Management has highlighted roughly $35 million in annualized savings from the combination, and the pace at which those synergies translate into improved profitability — measured through adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) — remains a central question.
Third, pay attention to seasonality and cash flow. CBIZ's business is heavily weighted toward its first-quarter tax season, so third-quarter results also provide insight into free cash flow generation and the company's balance sheet position ahead of the year-end. Finally, any commentary on demand for its advisory and capital markets practices, as well as updates to full-year guidance, will be closely parsed as indicators of broader middle-market business confidence.
Using Tickeron’s AI Screener for Earnings Research
In preparing for reports like this one from CBIZ, I often rely on Tickeron’s AI Screener to quickly surface comparable names and review technical and fundamental signals. The tool helps me scan across industries and performance metrics in a structured way, which adds context when evaluating earnings season opportunities without replacing my own analysis.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CBZ in +0.13% Uptrend, growing for three consecutive days on October 09, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CBZ advanced for three days, in 222 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on September 22, 2026. You may want to consider a long position or call options on CBZ as a result. In 53 of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Aroon Indicator entered an Uptrend today. In 164 of 268 cases where CBZ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
Bearish Trend Analysis
The 10-day RSI Indicator for CBZ moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 18 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 49%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBZ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
CBZ broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. CBZ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.613) is normal, around the industry mean (5.959). P/E Ratio (26.244) is within average values for comparable stocks, (32.103). Projected Growth (PEG Ratio) (1.219) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.026) among similar stocks. P/S Ratio (1.214) is also within normal values, averaging (9.694).
The Tickeron PE Growth Rating for this company is 74 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CBZ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of financial and employee benefits services
Industry OfficeEquipmentSupplies
Advertisement